Assessing the Clinical and Endoscopic Efficacy of Extended Treatment Duration with Different Doses of Mesalazine for Mild-to-Moderate Ulcerative Colitis beyond 8 Weeks of Induction

Introduction: High-strength mesalazine formulations play an important role in providing a convenient option to increase the dose in ulcerative colitis (UC) patients and therefore avoiding the switch to another therapeutic class. Higher doses of mesalazine may be required during periods of remission...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Geert D'Haens, Ekaterina Safroneeva, Helen Thorne, Raphaël Laoun
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Karger Publishers 2023-06-01
Cyfres:	Inflammatory Intestinal Diseases
Pynciau:	ulcerative colitis mesalazine disease extent maintenance high dose faecal calprotectin mayo endoscopic subscore
Mynediad Ar-lein:	https://beta.karger.com/Article/FullText/531372
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!